Lack of association between interleukin-1 gene cluster polymorphisms and glaucoma in Chinese subjects

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 5, 2007, Pages 2123-2126

  How, Alicia C S ^a   Aung, Tin ^a,b,c   Chew, Xinyi ^b   Yong, Victor H K ^b   Lim, Marcus C C ^a   Lee, Kelvin Y C ^a   Toh, Ju Yuan ^b   Li, Yuqing ^d   Liu, Jianjun ^d   Vithana, Eranga N ^b,c  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1;

ADULT; AGED; ARTICLE; CLOSED ANGLE GLAUCOMA; CONTROLLED STUDY; DNA POLYMORPHISM; GENE CLUSTER; GENE FREQUENCY; GENOTYPE; GONIOSCOPY; HAPLOTYPE; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ASIAN; CHROMOSOME 2; FEMALE; GENETICS; INTRAOCULAR HYPERTENSION; MALE; MIDDLE AGED; MULTIGENE FAMILY; OPEN ANGLE GLAUCOMA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; GENOTYPE; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HAPLOTYPES; HUMANS; INTERLEUKIN-1; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MULTIGENE FAMILY; OCULAR HYPERTENSION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34250170473     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1213     Document Type: Article

References (24)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Org. 1995;73:115-121.
3. Yip JL, Foster PJ. Ethnic differences in primary angle-closure glaucoma. Curr Opin Ophthalmol. 2006;17:175-180.
4. Craig JE, Mackey DA. Glaucoma genetics: where are we? - where will we go? Curr Opin Ophthalmol. 1999;10:126-134.
5. Kozlowski K, Walter MA. Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders. Hum Mol Gene. 2000;9:2131-2139.
6. Lehmann OJ, Ebenezer ND, Jordan T, et al. Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am J Hum Genet. 2000;67: 1129-1135.
7. Morissette J, Clepet C, Moisan S, et al. Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma. Nat Genet. 1998;19:319-321.
8. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991;109:1090-1095.
9. The CNTG authors. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126:487-497.
10. Wang N, Chintala SK, Fini ME, Schuman JS. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med. 2001;7:304-309.
11. Nicklin MJ, Weith A, Duff GW. A physical map region encompassing the human interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist genes. Genomics. 1994;19:382-384.
12. Hefler LA, Tempfer CB, Gregg AR. Polymorphisms within the interleukin-1 beta gene cluster and pre-eclampsia. Obstet Gynecol. 2001;97:664-668.
13. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978-989.
14. Wetmore JB, Hung AM, Lovett DH, Sen S, Quershy O, Johansen KL. Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int. 2005;68:278-284.
15. Kawaguchi Y, Tochimoto A, Ichikawa N, et al. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum. 2003; 48:186-192.
16. Buchs N, Di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2001;2:222-228.
17. Bradley JM, Anderssohn AM, Colvis CM, et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1β and TNFα. Invest Ophthalmol Vis Sci. 2000;41:422-430.
18. Pang IH, Helberg PE, Fleenor DL, et al. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:3485-3493.
19. Bradley JM, Vranka J, Colvis CM, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;339:2649-2658.
20. Kee C, Seo K. The effect of interleukin-1 alpha on outflow facility in rat eyes. J Glaucoma. 1997;6:246-249.
21. Chiou GC. Review: effects of nitric oxide on eye diseases and their treatment. J Ocul Pharmacol Ther. 2001;17:189-198.
22. Hall SK, Perregaux DG, Gabel CA, et al. Correlation of polymorphic variation in the promoter region of the interleukin-1beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum. 2004;50:1976-1983.
23. Lin HJ, Tsai SC, Tsai FJ, Chen WC, Tsai JJ, Hsu CD. Association of interleukin-1beta and receptor antagonist gene polymorphisms with primary open-angle glaucoma. Ophthalmologic. 2003;217: 358-364.
24. Freimer N, Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet. 2004;36:1045-1051.